Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Enzon Pharma Shares Rise on Prospects
Nov 21, 2008 04:38 PM
- Twenty Stocks to Short Sell
Jul 09, 2008 10:31 AM
- UPDATE: Consort Medical Fiscal Year Profit Falls On GBP10 Million Exubera Hit
Jun 24, 2008 06:21 AM
- UPDATE: Consort Medical Fiscal Year Profit Falls On GBP10 Million Exubera Hit
Jun 24, 2008 06:21 AM
- Crucell 2008 Annual General Meeting of Shareholders
Jun 02, 2008 08:59 AM
- NASDAQ Technical Picture - Bearish Outside Day
May 08, 2008 01:10 AM
- Ahead Of The Bell
Apr 09, 2008 09:37 AM
- MARKET SNAPSHOT: Dow Closes With Biggest Single-day Gain In Eight Weeks
Nov 13, 2007 04:30 PM
- MARKET SNAPSHOT: U.S. Stocks Rebound; Dow Surging More Than 270 Points
Nov 13, 2007 03:28 PM
- MARKET SNAPSHOT: U.S. Stocks Rebound; Dow Up More Than 200 Points
Nov 13, 2007 02:42 PM
- Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
Nov 06, 2008 04:42 PM
- Nektar Therapeutics to Webcast R&D Day on November 12th
Oct 27, 2008 08:31 AM
- Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
Oct 24, 2008 06:00 AM
- Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
Oct 23, 2008 04:15 PM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: AAPL, ICOG, NKTR, STSI, HA, AVGN
Oct 23, 2008 09:02 AM
- Positive Preclinical Data Demonstrating Anti-Tumor Activity of NKTR-105 (PEG-docetaxel) Presented at 20th EORTC-NCI-AACR Conference
Oct 23, 2008 06:01 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, DRRX, MDRX, NKTR, PRGN, AFFX
Oct 21, 2008 09:03 AM
- Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Oct 21, 2008 02:04 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: MFGD, LGDI, NGAS, SOLR, IILG, NKTR
Oct 20, 2008 09:01 AM
- Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
Oct 07, 2008 08:31 AM
- Form 4 Krivulka Joseph J For: Nov 14 (10K)
Nov 18, 2008 03:46 PM
- Form 4 WHITFIELD ROY A For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 WANG SUSAN For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 Labrucherie Gil M For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 Lingnau Lutz For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 LERNER IRWIN For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 KUEBLER CHRISTOPHER A For: Nov 14 (10K)
Nov 18, 2008 03:45 PM
- Form 4 BROWN MICHAEL A/CA For: Nov 14 (10K)
Nov 18, 2008 03:40 PM
- Form 4 Thomsen Jillian B. For: Nov 14 (10K)
Nov 18, 2008 03:40 PM
- Form 4 PATTON JOHN STUART For: Nov 14 (10K)
Nov 18, 2008 03:40 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
NKTR
|
Compare to S&P
|
| YTD |
-43.96 %
|
9.50 %
|
| 4 Weeks |
-6.70 %
|
3.73 %
|
| 12 Weeks |
1.90 %
|
61.92 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -11.11 %
|
|
EPS Growth in Last Year: -100.00 %
|
|
Sales Growth in Last Quarter: 5.09 %
|
|
Sales Growth in Last Quarter: -61.93 %
|
|
|
